Magic mushrooms, also known as psilocybin mushrooms, have been used for centuries for their psychoactive effects. However, there has been a lot of debate around their safety and potential risks. In this blog post, we’ll take a closer look at magic mushrooms and explore their potential dangers.
What are Magic Mushrooms?
Magic mushrooms contain the psychoactive compound psilocybin, which can cause changes in perception, mood, and thought. Psilocybin is classified as a Schedule I controlled substance in the United States, meaning it has no currently accepted medical use and a high potential for abuse.
Magic mushrooms are illegal in the UK. In 2005, the UK government classified psilocybin mushrooms as a Class A drug under the Misuse of Drugs Act. This means that it is illegal to possess, produce, sell, or supply magic mushrooms. The penalty for possession of magic mushrooms can include a fine and/or imprisonment, and the penalty for supplying or producing them can result in a more severe punishment. It’s important to note that while magic mushrooms may be legal in some other countries, it is illegal to import them into the UK, and doing so can result in criminal charges.
Effects of Magic Mushrooms
The effects of magic mushrooms can vary from person to person and depend on several factors, including the dosage, set, and setting. The effects usually start within 20-30 minutes of consumption and can last for up to six hours. Some common effects of magic mushrooms include:
- Changes in perception, such as seeing vivid colors and patterns
- Alterations in mood, such as euphoria or anxiety
- Changes in thought processes, such as increased creativity or introspection
- Physical effects, such as dilated pupils, increased heart rate, and nausea
In Conclusion
From treating depression to helping manage alcohol addiction, researchers say legal medical “magic mushrooms” have many potential benefits. “There’ve been some promising preliminary results in such areas such as the treatment of overwhelming existential anxiety in people who are facing the end of life,who have diagnoses of advanced-stage cancer,” Dr. Charles Grob, professor of psychiatry at the UCLA David Geffen School of Medicine, told Healthline.